Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 6101 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

R1 RCM Forms Special Committee to Evaluate Strategic Alternatives

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  R1 RCM

Arcutis Promotes Todd Tucker to Chief Human Resources Officer

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Arcutis Biotherapeutics, Inc.

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Tonix Pharmaceuticals Holding Corp.

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Biora Therapeutics, Inc.

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Daxor Corporation

ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  ACELYRIN INC.

Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Immuneering Corporation

Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding

Read more ››
By: GlobeNewswire - 11 Mar 2024

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference

Read more ››
By: GlobeNewswire - 11 Mar 2024

Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Hyku Biosciences, Inc.

Theriva™ Biologics to Participate in the BIO-Europe Spring Conference

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Theriva Biologics, Inc.

Reviva to Present at the UBS Virtual CNS Day

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Reviva Pharmaceuticals, Inc.

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Avenue Therapeutics, Inc.

ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  ACELYRIN INC.

Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients

Read more ››
By: GlobeNewswire - 11 Mar 2024

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Napigen Inc.

Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Aprea Therapeutics, Inc.

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Integra LifeSciences

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 11 Mar 2024

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Aprea Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑